Regulatory record
RelieVRx FDA 510(k) Summary — K243417
FDA summary describing RelieVRx, its intended use, device classification, and relationship to the predicate device.
VRPain management
Source reviewed
Browse reviewed public metadata. Trust labels describe provenance—not clinical endorsement.
Search by clinical need, modality, organization, or use case. Every result shows its source and review state.
FDA summary describing RelieVRx, its intended use, device classification, and relationship to the predicate device.
A 2025 article tracing development, authorization, and implementation considerations for a VR-delivered chronic lower-back-pain program.